Market Tracker

02/10 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

1.98
Delayed Data
As of Feb 10
 -0.09 / -4.35%
Today’s Change
1.50
Today|||52-Week Range
5.05
-35.50%
Year-to-Date

Today’s Trading

Previous close2.07
Today’s open2.04
Day’s range1.87 - 2.21
Volume1,198,984
Average volume (3 months)952,947
Market cap$196.1M
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+13.73%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXGNAxoGen Inc-0.01-0.20%
EARSAuris Medical Holdin...-0.12-2.85%
CUTRCutera Inc-0.62-5.61%
FONRFonar Corp-0.07-0.47%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts